SCA
MDT icon

STALEY CAPITAL ADVISERS’s Medtronic MDT Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,624
Closed -$204K – 191
2021
Q3 		$204K Hold
1,624
– – 0.01% 174
2021
Q2 		$202K Buy
+1,624
New +$204K 0.01% 173

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

STALEY CAPITAL ADVISERS's MDT Position: Q4 2021 in Review

STALEY CAPITAL ADVISERS sold out of Medtronic (MDT) in Q4 2021, closing a stake of 1,624 shares — an estimated $204K sold.

STALEY CAPITAL ADVISERS first reported a position in MDT in Q2 2021 and held it in 2 quarters. The position peaked at $204K in Q3 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • STALEY CAPITAL ADVISERS reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • STALEY CAPITAL ADVISERS sold 1,624 Medtronic shares in Q4 2021, an estimated $204K.
  • STALEY CAPITAL ADVISERS first reported a position in Medtronic in Q2 2021 and held it in 2 quarters.
  • STALEY CAPITAL ADVISERS's Medtronic position peaked at $204K in Q3 2021.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q4 2021, filed 8 Feb 2022.